Ipilimumab/pembrolizumabAutoimmune hepatitis and adrenal crisis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1687卷 / 1期

关键词：

D O I：

10.1007/s40278-018-41545-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：124 / 124

相关论文

共 50 条

[1] Ipilimumab/pembrolizumabAutoimmune diabetes: case report
[J]. Reactions Weekly, 2019, 1784 (1) : 158 - 158
[2] Ipilimumab/pembrolizumabAutoimmune colitis and pancreatitis: case report
[J]. Reactions Weekly, 2016, 1617 (1) : 145 - 145
[3] PembrolizumabAutoimmune hepatitis: case report
[J]. Reactions Weekly, 2017, 1669 (1) : 210 - 210
[4] PembrolizumabAutoimmune hepatitis: case report
[J]. Reactions Weekly, 2021, 1884 (1) : 355 - 355
[5] Ipilimumab/pembrolizumabAutoimmune hepatitis and haemolytic anemia with pure red cell aplasia (first report): case report
[J]. Reactions Weekly, 2016, 1599 (1) : 127 - 127
[6] PembrolizumabAutoimmune diabetes and hepatitis: case report
[J]. Reactions Weekly, 2017, 1658 (1) : 371 - 371
[7] Ipilimumab/pembrolizumabAutoimmune diabetes, diabetic ketoacidosis and thyroiditis: case report
[J]. Reactions Weekly, 2017, 1645 (1) : 168 - 168
[8] PembrolizumabAutoimmune hepatitis and aseptic meningitis: case report
[J]. Reactions Weekly, 2019, 1784 (1) : 210 - 210
[9] Ipilimumab/pembrolizumabAutoimmune-mediated brainstem encephalitis: case report
[J]. Reactions Weekly, 2017, 1661 (1) : 184 - 184
[10] Ipilimumab/pembrolizumabAutoimmune colitis and acute lymphocytic gastritis: case report
[J]. Reactions Weekly, 2020, 1831 (1) : 172 - 172

← 1 2 3 4 5 →